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Abstract
Neutrophils isolated from a child with severe leukocyte adhesion deficiency 1 (LAD1) had a complete absence of
expression of the CD11/CD18 L2 integrin family of adhesion molecules, and were shown to be deficient in the in vitro
adhesion and migration properties. However, we found that interleukin-8 (IL8), a potent chemoattractant for neutrophils,
and sputum sol phase induced these LAD1 neutrophils to migrate through an endothelial cell layer in vitro, and confirmed
that this migration was CD18-independent. These findings add to evidence of CD18-independent mechanisms of neutrophil
recruitment, in particular neutrophil infiltration into the lungs, where IL8 may be an important recruitment factor. ß 2000
Elsevier Science B.V. All rights reserved.
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1. Introduction
Leukocyte adhesion de¢ciency 1 (LAD1) is a rare,
inherited disease characterised by severe, recurrent
bacterial infections of the skin and mucosa, impaired
pus formation and wound healing. These clinical
symptoms are due to a defect in leukocyte (especially
neutrophils) migration, from the blood into the tis-
sues at sites of infection or injury. This defect is
directly due to reduced expression of a family of
adhesion molecules found only on leukocytes, known
as the L2 integrins [1]. This family of heterodimers
comprise three members: LFA-1 (CD11a/CD18),
Mac-1 (CD11b/CD18), and gp150,95 (CD11c/
CD18), sharing the common subunit, CD18. The
primary genetic defect in LAD1 is in the L2 subunit
(CD18) gene, resulting in an absent or structurally
abnormal L2 subunit that a¡ects expression of all
three adhesion molecules. Children with LAD1
have a marked leukocytosis, but biopsies of infection
lesions show a complete absence of neutrophil in¢l-
tration into the tissues. The impaired migration of
LAD neutrophils has been demonstrated in vivo, us-
ing Rebuck skin windows, and a number of in vitro
CD18-dependent neutrophil functions including che-
motaxis, adhesion to endothelial cells and phagocy-
tosis, are also defective [2]. However, CD18-inde-
pendent mechanisms of cell adhesion are also
known to exist [3^6], and recent evidence from ani-
mal studies suggests that CD18-independent mecha-
nisms are important in neutrophil in¢ltration into the
lungs of rabbits [7^9]. Furthermore, there is evidence
that such mechanisms also occur in the human lung.
Post mortem histology on a child with severe LAD1
revealed neutrophil accumulation in broncho-pneu-
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monial foci of the lungs, but a complete absence of
neutrophils in skin and intestinal lesions [10].
We report in vitro evidence that neutrophils iso-
lated from a child with severe LAD1 are able to
migrate through endothelial cells in response to
IL8, a potent chemoattractant that may be a major
factor recruiting neutrophils to the lungs in a number
of pulmonary disorders [11].
2. Case report and methods
The patient was a male infant, who presented at 8
weeks of age with delayed umbilical cord separation,
periumbilical erythema and an infected skin rash on
one leg, associated with a marked leukocytosis (WBC
93U109 cells/l ; 74% neutrophils). The lesions re-
solved on treatment with i.v. antibiotics, and the
cord ¢nally separated at 3 months. The parents are
¢rst cousins and a diagnosis of LAD was suspected
in the child because his sister had died a year previ-
ously with LAD despite bone marrow transplanta-
tion. Initial laboratory tests con¢rmed the diagnosis
by showing a total absence of neutrophil chemotaxis,
and severely reduced levels of CD11/CD18 on both
neutrophils and lymphocytes.
2.1. Materials and monoclonal antibodies
Recombinant human IL8 (72 amino acid form,
monocyte-derived) was obtained from Genzyme Di-
agnostics (West Malling, UK). Formyl-met-leu-phe
(FMLP) and Nonidet P40 were obtained from Sigma
(Poole, Dorset, UK). Anti-CD11a (clone 38), anti-
CD11b (clone 44) and anti-CD11c (clone 3.9) were
kindly donated by Dr. Nancy Hogg (ICRF, UK),
and were all hybridoma tissue culture supernatants
used neat. Anti-CD18 (clone MHM23) was obtained
from Dako Diagnostics Ltd (High Wycombe, Bucks,
UK). Anti-CR1 (complement receptor 1; clone E11)
was obtained from Seralab (Crawley Down, UK).
Sputum sol phase was obtained from six patients
with purulent bronchiectasis and pooled.
2.2. Immuno£uorescence
Expression of cell surface antigens was measured
by £ow cytometry using a FACScan (Becton Dick-
inson, Mountain View, CA, USA). Control and pa-
tient neutrophils were incubated with 10 ml of each
of anti-CD11a, anti-CD11b, anti-CD11c, anti-CD18,
and a non-speci¢c control monoclonal antibody of
the same subclass (IgG1). After washing, bound anti-
bodies were detected using £uorescently conjugated
F9ab2 goat anti-mouse Ig (Dako Diagnostics).
2.3. Immunoprecipitation
Expression of the cell surface antigens CD11/
CD18 was further investigated by the more sensitive
technique of immunoprecipitation. Freshly isolated
neutrophils were surface radiolabelled with 125I by
the lactoperoxidase method [12], then lysed as de-
scribed by Kishimoto et al. [13]. Free iodine was
removed from the 125I bound to cell membrane pro-
teins by G25 Sephadex chromatography. Equal
amounts of lysate (2.2U106 cpm) from 125I-labelled
normal and LAD patient neutrophils were used for
immunoprecipitation of CD11a, CD11b, CD11c,
CD18 and CR1. The lysates were extensively pre-
cleared by incubation with Staph. A cells to remove
proteins that bind non-speci¢cally to protein A. The
lysates were then incubated with the relevant mono-
clonal antibodies, and the resultant immune com-
plexes formed with their speci¢c antibodies in the
cell lysates were removed from solution by protein
A precipitation. The immunoprecipitates were then
washed extensively, denatured with sodium dodecyl
sulphate (SDS), analysed by 7.5% SDS-polyacryla-
mide gel electrophoresis, and visualised by autora-
diography.
2.4. Neutrophil puri¢cation
Peripheral neutrophils were isolated from 5 ml of
patient blood and 20 ml of blood from normal adult
donors, collected into preservative-free sodium hep-
arin (20 U/ml), by dextran sedimentation of the er-
ythrocytes followed by centrifugation over Lympho-
prep (400Ug, 20 min, at room temperature (RT):
Nycomed, Sheldon, Birmingham, UK). Contaminat-
ing erythrocytes in the neutrophil pellet were hypo-
tonically lysed, and the puri¢ed neutrophils resus-
pended in RPMI with 5% foetal calf serum (FCS)
(Gibco, Paisley, Scotland). Neutrophils were labelled
with 51chromium as described by Gallin et al. [14]
BBADIS 61893 28-10-99
C.M. Morland et al. / Biochimica et Biophysica Acta 1500 (2000) 70^76 71
and resuspended in assay medium (RPMI with 5%
FCS).
2.5. Endothelial cell culture
Endothelial cells were isolated from human umbil-
ical cord veins as described previously [15], main-
tained in RPMI containing a 20% pooled human
serum. Con£uent primary cultures were used for
seeding adhesion assay plates and the ¢lter inserts
of Transwells (Costar, High Wycombe, UK).
2.6. Adhesion assay
The adherence of neutrophils to con£uent endo-
thelial cell monolayers (con¢rmed by microscopy)
grown in 96-well plates was determined as described
previously [15], with the following modi¢cations.
51Chromium-labelled neutrophils (105 cells in 100
Wl) were added to triplicate wells of unstimulated
endothelial cells or endothelial cells preincubated
with LPS (1 Wg/ml, 4 h, 37‡C). After incubation for
30 min at 37‡C, the non-adherent cells were removed
by aspiration and three gentle washes of the endo-
thelial cell layers. The adherent neutrophils were then
quanti¢ed by addition of 1% Nonidet P40 to lyse the
cells, and gamma emissions for each well counted.
2.7. Transendothelial migration assay
The migration of neutrophils through con£uent
endothelial cell layers was assessed using Transwell
chambers, which consist of small inserts with poly-
carbonate ¢lter bases (3 Wm pore size) ¢t into the
wells of a 24-well plate. Endothelial cells were grown
to con£uence (as determined by microscopy) on the
¢bronectin-coated ¢lter bases, then washed gently
with assay medium, and 100 Wl of medium plus 100
Wl (5U105 cells) of 51chromium-labelled neutrophils
were added to the insert wells. Chemotactic agent
(900 Wl), at an optimal concentration found to be
1038 M, 5U1039 M, and a 1 in 5 dilution for
FMLP, IL8 and sputum was placed beneath the en-
dothelial cell layers. After allowing migration to pro-
ceed for 1 h (37‡C), the inserts were removed, the
undersides rinsed with PBS with 0.01% EDTA to
remove any cells remaining attached, and the number
of cells migrated was determined by measuring the
radioactivity of the cell suspension in the lower wells.
For blocking experiments, 100 Wl of anti-CD18
monoclonal antibody (1/60, optimal working dilu-
tion) was added in place of medium to the insert
wells at the same time as the neutrophils.
2.8. Statistics
Data were analysed by Student’s t-test using Stat-
works version 1.2, Cricket software.
3. Results
Surface expression of the leukocyte adhesion mol-
Fig. 1. Immunoprecipitation of CD11a, CD11c and CD18 from
healthy adult neutrophils (A) and de¢cient patient neutrophils
(B). Lysates of 125I cell surface-labelled neutrophils were immu-
noprecipitated with anti-CR1 (lane 1), anti-CD11a (lane 2),
anti-CD11c (lane 3), anti-CD18 (lane 4) and control antibody
to non-speci¢c antigen (lane 5). The immunoprecipitates were
denatured with SDS to separate the co-precipitated KL subunits,
and analysed by 7.5% SDS-PAGE and autoradiography. B con-
¢rms immunoprecipitation of CR1 but no CD11a, CD11c or
CD18 from the patient’s neutrophils.
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ecules LFA-1, Mac-1, and gp150,95 was found to be
absent on the patient’s neutrophils by immuno£uo-
rescent £ow cytometry analysis. This was con¢rmed
by immunoprecipitation of 125I surface-labelled neu-
trophils from the patient and a normal subject (Fig.
1). The anti-CD11a and anti-CD11c antibodies pre-
cipitated with the respective K subunits non-cova-
lently associated with the common L subunits (Fig.
1A, lanes 2 and 3) from normal neutrophils. (Anti-
body to CD11b would not precipitate CD11b from
either normal or patient neutrophils.) The anti-CD18
antibody precipitated the L subunit and the three K
subunits non-covalently associated with it from nor-
mal neutrophils (Fig. 1A, lane 4). However, neutro-
phils from the patient were de¢cient in all these mol-
ecules (Fig. 1B, lanes 2, 3, 4). As a positive control,
CR1 was precipitated from both patient and normal
neutrophils (Fig. 1A and B, lane 1), whereas a non-
speci¢c IgG1 mouse monoclonal antibody was used
as a negative control (Fig. 1A and B, lane 5).
The ability to generate superoxide anions, an ad-
herence-independent neutrophil function, was nor-
mal for both unstimulated and FMLP-stimulated pa-
tient neutrophils (data not shown). In contrast, the
adhesion of these neutrophils was found to be re-
duced to both unstimulated endothelial cells and
LPS-stimulated endothelial cells compared to normal
neutrophils (P6 0.05). However, the patient’s neu-
trophils demonstrated some adhesion to endothelial
cells which was increased when the endothelial cells
were stimulated with LPS (Fig. 2; P6 0.05) which
may re£ect selectin-mediated adhesion.
Random migration of the child’s neutrophils
through an endothelial cell layer was diminished
and there was no response to FMLP (1038 M),
whereas normal neutrophils showed increased migra-
tion to FMLP (Fig. 3). In contrast, however, when
IL8 (5U1039 M) or sputum sol was used as the
chemoattractant, the LAD neutrophils showed an
increase in transendothelial migration compared to
random migration and migration to FMLP
(P6 0.001). Nevertheless the migration to IL8 and
sputum sol were still reduced, however, compared
to normal. Since we had demonstrated that the
child’s neutrophils did not express CD11/CD18 ad-
hesion molecules, the migration of these cells to IL8
and sputum should be CD18-independent. This was
con¢rmed using a blocking antibody to CD18 (Fig.
Fig. 2. Adhesion of neutrophils from a normal (control) or
LAD patient to endothelial cell monolayers. Endothelial cells
were either untreated or pretreated with LPS. Histograms are
means þ S.D. of three experiments (each experiment performed
in triplicate). Adhesion of LAD neutrophils is signi¢cantly less
than normal (*P6 0.05) to both control and stimulated endo-
thelial cells, but is increased in the presence of LPS-stimulated
cells.
Fig. 3. Transendothelial migration of normal and LAD neutro-
phils. Normal neutrophils have signi¢cantly increased migration
to the chemoattractants FMLP, IL8 and sputum compared to
control random migration (n = 5; **P6 0.01). LAD neutrophils
demonstrated no response to FMLP, but did migrate both to
IL8 and sputum (n = 5; ###P6 0.001).
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4). The presence of anti-CD18 antibody abolished or
reduced normal neutrophil transendothelial migra-
tion to IL8 and sputum (Fig. 4) but had no signi¢-
cant e¡ect on the LAD neutrophil migration (Fig.
4B).
4. Discussion
This study described a child with classic LAD1
syndrome, whose neutrophils have a complete ab-
sence of CD11/CD18 integrin molecule expression.
There are two phenotypes of L2 integrin expression
in LAD patients; a severe de¢ciency where CD11/
CD18 surface expression is absent and a moderate
phenotype where 2^12% expression is detectable on
the leukocytes. The patient described here would ap-
pear to have the severe phenotype, which is associ-
ated with more frequent, often life-threatening, infec-
tions.
We present in vitro evidence that neutrophils iso-
lated from our patient are able to migrate through an
endothelial cell layer in response to IL8 or bronchi-
al secretions by a CD18-independent mechanism.
Transendothelial migration of these CD18-de¢cient
neutrophils was not increased in response to
FMLP, or through LPS-stimulated endothelial cells
(normal neutrophils showed a two-fold increase in
migration through LPS-stimulated endothelial cells
compared to random migration, data not shown).
However signi¢cant migration of the LAD1 neutro-
phils was seen to IL8 and bronchial secretions, which
was not reduced by antibody to CD18, unlike nor-
mal neutrophils (Fig. 4B).
IL8 has been implicated as a potentially important
mediator in lung in£ammation [11], since it is a
powerful chemotactic agent for neutrophils and an
activating agent inducing their degranulation [16].
Neutrophil in¢ltration is a pathogenic event in a
number of pulmonary diseases, e.g. adult respiratory
distress syndrome (ARDS), pulmonary ¢brosis,
bronchiectasis. Furthermore, levels of IL8 capable
of signi¢cant neutrophil chemotactic activity have
been detected in bronchoalveolar lavage £uid from
ARDS patients [17], sputum from cystic ¢brosis,
bronchiectasis, and chronic bronchitis patients [18],
and in pleural e¡usions from patients with empyema
[19,20]. Levels of IL8 correlated with the total num-
bers of neutrophils present in empyema, implicating
IL8 as a major factor causing the neutrophil recruit-
ment. Localised production of IL8 in the lung may
be due to activated alveolar macrophages which not
only secrete IL8 but also produce IL1 and TNFK
which can stimulate non-in£ammatory cells such as
Fig. 4. E¡ect of antibody to CD18 on normal and LAD neu-
trophil migration (n = 4). Normal neutrophil migration to IL8 is
reduced to the level of random migration in the presence of
antibody (A). No signi¢cant reduction in response to LAD neu-
trophils to IL8 was observed in the presence of antibody (B).
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lung ¢broblasts and type II epithelial cells to produce
IL8 [21,22].
Our report demonstrates that IL8 can cause neu-
trophil recruitment via a CD18-independent mecha-
nism and supports a growing body of evidence,
mainly from animal studies, that both CD11/CD18-
dependent and independent mechanisms may be im-
portant in the migration of neutrophils into the lung.
The main mechanism may depend on the type of
stimulus causing the in£ammation or may be site-
dependent. For instance, Doerschuk et al. [7] found
that neutrophil emigration into the lung in response
to Escherichia coli endotoxin-induced in£ammation
was completely blocked by CD18, but that the emi-
gration was CD18-independent in response to Strep-
tococcus pneumoniae or HCI-induced in£ammation.
In addition, Keeney et al. [23] and Motosugi et al.
[24] demonstrated that non-bacterial lung in£amma-
tion can be mediated independently of CD11/18
mechanisms. This CD18-independent mechanism
also appeared to be speci¢c for lung in£ammation,
as antibody to CD18 could abolish neutrophil migra-
tion into S. pneumoniae-induced in£ammatory sites
in the peritoneum of the same animal. More recently
CD18-independent migration has been observed into
the lung in response to C5a or IL1K [9]. It has also
been shown in a rabbit model of haemorrhagic shock
that antibody to CD18 could improve survival and
reduce tissue damage, but not the lung injury [25].
The occurrence of CD18-independent neutrophil
migration in the lung may be due to factors released
locally by activation of the resident population of
alveolar macrophages. Winn and Harlan [26] have
described CD18-independent neutrophil migration
into the peritoneum of rabbits due to release of a
factor by macrophages already present at the in£am-
matory site [27]. Furthermore, there is supportive
evidence for a CD18-independent mechanism of neu-
trophil migration into the human lung. Post mortem
examination of the lungs of a severe LAD patient
showed neutrophil accumulation in foci of broncho-
pneumonia, whereas this did not occur at in£amma-
tory sites in the skin and intestines [10].
There is increasing evidence for the involvement of
other adhesion molecules in neutrophil migration
into tissues. Adhesion to the endothelium is an early
requisite step in this process, and the initial rolling of
neutrophils along the endothelium, leading to their
¢rm adhesion, is mediated by members of the selectin
family of adhesion molecules [28]. These molecules
may be less important than the integrins since type
II LAD, where selectin expression is defective, results
in a mild disorder [29] compared to CD18 de¢ciency
[29]. Evidence for CD18-independent mechanisms of
adhesion to cytokine-activated endothelial cells has
also been reported by Dobrina et al. [3], who showed
that normal neutrophils pretreated with antibody to
CD18, and LAD neutrophils, retained increased lev-
els of adhesion to cytokine-activated endothelial cells
compared to unstimulated endothelium supporting
the data presented here. This stimulated adhesion
must be via a CD18-independent mechanism, and
both L-selectin on the neutrophil, and E-selectin on
the endothelial cells have been implicated [30]. In
the lung, Mulligan et al. [31] have found E-selectin
to be upregulated in the vasculature during immune
complex-induced lung in£ammation in rats, and
systemic treatment with antibody to E-selectin re-
duced neutrophil in¢ltration and vascular injury. In
addition Jutila et al. [32] have shown that antibody
to L-selectin markedly reduced neutrophil in¢ltration
in experimental peritoneal in£ammation in the
mouse.
In conclusion we present the case of a 9 month old
boy with severe LAD. Neutrophils isolated from this
child showed:
b (a) increased adhesion to LPS-stimulated endothe-
lial cells, and
b (b) migration through an endothelial cell layer in
response to IL8 and sputum.
This migration could not be blocked by antibody
to CD18. We therefore conclude that in the presence
of an appropriate stimulus human neutrophils can
migrate in a CD18-independent manner. The inves-
tigation of LAD neutrophil migration and the role of
other adhesion molecules such as the selectins, may
help to elucidate more clearly the mechanisms of
neutrophil recruitment in in£ammation of the lung.
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